Literature DB >> 11012492

Effects of peribulbar bupivacaine as an adjunct to general anaesthesia on peri-operative outcome following retinal detachment surgery.

D Shende1, S Sadhasivam, R Madan.   

Abstract

Sixty premedicated, ASA physical status I or II patients weighing > 25 kg scheduled for elective retinal detachment repair were randomly assigned to receive either peribulbar block with 10 ml of 0.25% bupivacaine (block group) or intravenous morphine 150 microg.kg-1 (morphine group), prior to the induction of general anaesthesia (n = 30 in each group). Patients were evaluated for intra-operative oculocardiac reflex, peri-operative pain relief, recovery from anaesthesia and postoperative nausea and vomiting. Apart from significantly reducing the incidence of oculocardiac reflex (30% vs. 70%, p = 0.0019), peribulbar bupivacaine also attenuated the severity of the reflex. Postoperative pain relief was superior in the block group. More block group patients had the maximum recovery score in the immediate postoperative period (80% vs. 27%, p < 0. 0001) and they achieved complete recovery significantly faster than the morphine group (17.3 (14.7) min vs. 66.7 (29.7) min, p < 0.0001). The incidence (40% vs. 77%, p = 0.004) and severity of postoperative nausea and vomiting were significantly less in the block group. In summary, peribulbar bupivacaine, when administered together with general anaesthesia, attenuated oculocardiac reflex, provided comparable intra-operative and superior postoperative analgesia, resulted in significantly earlier and better recovery from anaesthesia, and significantly reduced the incidence and severity of postoperative nausea and vomiting.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11012492     DOI: 10.1046/j.1365-2044.2000.01535.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  9 in total

1.  Trigemino-cardiac reflex during orbital floor reconstruction: a case report and review.

Authors:  Sunil Vasudev; K Sudhakara Reddy
Journal:  J Maxillofac Oral Surg       Date:  2011-08-10

2.  Randomised, masked study of local anaesthesia administered prior to external dacryocystorhinostomy under general anaesthesia.

Authors:  Richard L Scawn; Matthew J Allen; Geoffrey E Rose; David H Verity
Journal:  Eye (Lond)       Date:  2018-09-18       Impact factor: 3.775

Review 3.  The Oculocardiac Reflex: A Review.

Authors:  Robert W Arnold
Journal:  Clin Ophthalmol       Date:  2021-06-24

4.  The efficacy of 0.75% levobupivacaine versus 0.75% ropivacaine for peribulbar anesthesia in vitreoretinal surgery.

Authors:  Ashraf M Ghali
Journal:  Saudi J Anaesth       Date:  2012-01

5.  Postoperative Analgesic Efficacy of Sub-Tenon's Block with Levobupivacaine in Retinal Surgery under General Anesthesia.

Authors:  Ola T Abdeldayem; Ghada F Amer; Mohamed G Abdulla
Journal:  Anesth Essays Res       Date:  2019 Jul-Sep

6.  Intra-Arterial Lidocaine Blunts the Trigeminocardiac Reflex during Endovascular Treatment of a Carotid-Cavernous Fistula.

Authors:  Renee L Coleman; Dmitri Bezinover; Douglas C Jones; Kevin M Cockroft; Uma R Parekh
Journal:  Case Rep Anesthesiol       Date:  2021-01-05

7.  Anesthetic Approach in Ambulatory Vitrectomy: Peribulbar Block vs. Balanced General Anesthesia.

Authors:  Bárbara Gouveia; Leonardo Ferreira; Paula Maia
Journal:  Anesthesiol Res Pract       Date:  2022-03-28

8.  [Peribulbar block combined with general anesthesia in babies undergoing laser treatment for retinopathy of prematurity: a retrospective analysis].

Authors:  Daniela Filipa Rodrigues Pinho; Cátia Real; Leónia Ferreira; Pedro Pina
Journal:  Braz J Anesthesiol       Date:  2018-03-12

9.  Preventive Analgesia, Hemodynamic Stability, and Pain in Vitreoretinal Surgery.

Authors:  Michał Jan Stasiowski; Aleksandra Pluta; Anita Lyssek-Boroń; Magdalena Kawka; Lech Krawczyk; Ewa Niewiadomska; Dariusz Dobrowolski; Robert Rejdak; Seweryn Król; Jakub Żak; Izabela Szumera; Anna Missir; Przemysław Jałowiecki; Beniamin Oskar Grabarek
Journal:  Medicina (Kaunas)       Date:  2021-03-12       Impact factor: 2.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.